Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training

Feasibility and Efficacy of the Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training (U-SMART) on Mild Cognitive Impairment

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01628653

Acronym

U-SMART

Enrollment

Registered

2012-06-27

Start date

2011-06-30

Completion date

2012-02-29

Last updated

2012-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Keywords

Mild cognitive impairment, Cognitive rehabilitation, Cognitive therapy, Spaced retrieval Training, Alzheimer's disease, Memory enhancement, U-healthcare

Brief summary

The purpose of this study is to examine feasibility and efficacy of the Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training (U-SMART) in the elderly individuals with mild cognitive impairment (MCI).

Detailed description

The Spaced Retrieval-based Memory Advancement and Rehabilitation Training (SMART) which consisted of 24 one-hour face-to-face sessions (Lee, Park et al. 2009) was developed based on the spaced retrieval training (SRT), which was effective in improving memory retention span of very mild to mild Alzheimer's disease patients. The Ubiquitous SMART (U-SMART) by transforming the current SMART to a self-administered program using an application working on IPAD was developed, and was examined its feasibility and efficacy in the elderly individuals with mild cognitive impairment.

Interventions

DEVICEU-SMART

4-weeks' training

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

55 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Aged 55-90 * Educational level above 1 year and confirmed literacy * Diagnosed to mild cognitive impairment by International Working Group on Mild Cognitive Impairment * Clinical Dementia Rating (CDR) of 0 or 0.5

Exclusion criteria

* Diagnosed to dementia by DSM-IV * Evidence of delirium, confusion * Any neurological conditions causing cognitive decline such as Parkinson's disease, brain hemorrhage, brain tumor, normal pressure hydrocephalus * Evidence of severe cerebrovascular pathology * History of loss-of-consciousness over 1 hour due to head trauma or repetitive head trauma of mild severity * History of substance abuse or dependence such as alcohol * Presence of depressive symptoms that could influence cognitive function * Presence of medical comorbidities that could result in cognitive decline * Use of medication that could influence cognitive function seriously

Design outcomes

Primary

Measure	Time frame	Description
the five-point Likert scales for satisfaction and compliance	after 4-weeks treatment	To evaluate the feasibility of the U-SMART, the five-point Likert scales for satisfaction and compliance were applied to all participants.
Word List Memory Test of the CERAD Neuropsychological Assessment Battery	after 4-weeks treatment	To evaluate the efficacy of the U-SMART, the Word List Memory Test (WLMT) of the CERAD neuropsychological assessment battery was applied to all participants.

Secondary

Measure	Time frame
Mini-Mental State Examination (MMSE)	after 4-weeks treatment

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026